Black Friday saleUp to 70% OFF
CCC

CLINICAL LASERTHERMIA SYSTEMS AB SER. B

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

CLS_B chart


Full chart

Key stats


Market capitalization
‪62.69 M‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−6.26 SEK
Net income (FY)
‪−79.79 M‬ SEK
Revenue (FY)
‪8.27 M‬ SEK
Shares float
‪12.76 M‬
Beta (1Y)
1.07

Employees


Employees (FY)
17
Change (1Y)
+3 +21.43%
Revenue / Employee (1Y)
‪48.03 K‬ SEK
Net income / Employee (1Y)
‪−463.26 K‬ SEK

About CLINICAL LASERTHERMIA SYSTEMS AB SER. B


Sector
Health Technology
Industry
Medical Specialties
CEO
Dan J. Mogren
Website
clinicallaser.se
Headquarters
Lund
Founded
2006
ISIN
SE0022049920
FIGI
BBG001Y25W63
Clinical Laserthermia Systems AB engages in the development and manufacture of pharmaceutical products. It offers TRANBERG, a Thermal Therapy System and specially designed sterile disposable products for safe, gentle and effective treatment of cancerous tumors that is marketed for image-guided laser ablation and for treatment with immuno-stimulating interstitial laser thermotherapy. The company was founded by Karl-Göran Tranberg, Lars-Erik Thomas Eriksson, and Per-Hakan Henriksson on March 9, 2006 and is headquartered in Lund, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

CLS_B news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CLS_B is 4.40 SEK — it has increased by 19.05% in the past 24 hours. Watch CLINICAL LASERTHERMIA SYSTEMS AB SER. B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange CLINICAL LASERTHERMIA SYSTEMS AB SER. B stocks are traded under the ticker CLS_B.
CLS_B stock has risen by 14.21% compared to the previous week, the month change is a −2.17% fall, over the last year CLINICAL LASERTHERMIA SYSTEMS AB SER. B has showed a −83.82% decrease.
We've gathered analysts' opinions on CLINICAL LASERTHERMIA SYSTEMS AB SER. B future price: according to them, CLS_B price has a max estimate of 14.00 SEK and a min estimate of 14.00 SEK. Watch CLS_B chart and read a more detailed CLINICAL LASERTHERMIA SYSTEMS AB SER. B stock forecast: see what analysts think of CLINICAL LASERTHERMIA SYSTEMS AB SER. B and suggest that you do with its stocks.
CLS_B reached its all-time high on Jan 15, 2013 with the price of 5,374.20 SEK, and its all-time low was 3.60 SEK and was reached on Nov 20, 2024. View more price dynamics on CLS_B chart.
See other stocks reaching their highest and lowest prices.
CLS_B stock is 6.82% volatile and has beta coefficient of 1.07. Track CLINICAL LASERTHERMIA SYSTEMS AB SER. B stock price on the chart and check out the list of the most volatile stocks — is CLINICAL LASERTHERMIA SYSTEMS AB SER. B there?
Today CLINICAL LASERTHERMIA SYSTEMS AB SER. B has the market capitalization of ‪62.69 M‬, it has decreased by −7.80% over the last week.
Yes, you can track CLINICAL LASERTHERMIA SYSTEMS AB SER. B financials in yearly and quarterly reports right on TradingView.
CLINICAL LASERTHERMIA SYSTEMS AB SER. B revenue for the last quarter amounts to ‪5.40 M‬ SEK, despite the estimated figure of ‪5.40 M‬ SEK. In the next quarter, revenue is expected to reach ‪8.50 M‬ SEK.
CLS_B net income for the last quarter is ‪−12.97 M‬ SEK, while the quarter before that showed ‪−13.59 M‬ SEK of net income which accounts for 4.59% change. Track more CLINICAL LASERTHERMIA SYSTEMS AB SER. B financial stats to get the full picture.
No, CLS_B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 25, 2024, the company has 17.00 employees. See our rating of the largest employees — is CLINICAL LASERTHERMIA SYSTEMS AB SER. B on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CLINICAL LASERTHERMIA SYSTEMS AB SER. B EBITDA is ‪−56.85 M‬ SEK, and current EBITDA margin is −763.06%. See more stats in CLINICAL LASERTHERMIA SYSTEMS AB SER. B financial statements.
Like other stocks, CLS_B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CLINICAL LASERTHERMIA SYSTEMS AB SER. B stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CLINICAL LASERTHERMIA SYSTEMS AB SER. B technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CLINICAL LASERTHERMIA SYSTEMS AB SER. B stock shows the sell signal. See more of CLINICAL LASERTHERMIA SYSTEMS AB SER. B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.